Last reviewed · How we verify
NCT04167072
Observation vs Early Removal of LAMS in EUS Guided Cholecystoenterostomy
NA trial testing Stent removal in Cholecystitis, Acute. Withdrawn.
31 January 2021
Quick facts
| Lead sponsor | Texas Tech University Health Sciences Center, El Paso |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Start date | 1 November 2019 |
| Primary completion | 31 January 2021 |
| Estimated completion | 31 January 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Stent removal
Conditions studied
- Cholecystitis, Acute — all drugs for Cholecystitis, Acute →
- Cholecystitis; Gallstone — all drugs for Cholecystitis; Gallstone →
Sponsor
Texas Tech University Health Sciences Center, El Paso
Who can join
Adults 18 to 100, any sex, with Cholecystitis, Acute or Cholecystitis; Gallstone. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will compare the outcomes of patients with gallstone related cholecystitis who are poor surgical candidates undergoing EUS guided cholecystoenterostomy via a lumen apposing metal stent (LAMS).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04167072
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Stent removal
Trials testing the same drug.
- NCT03652285 — UAS-RBS: a Safety Study · NA · completed
Other recruiting trials for Cholecystitis, Acute
Currently open trials in the same condition.
- NCT06815822 — Prevention of Postoperative Hernias in Emergency Surgery · recruiting
- NCT06656299 — EOIB for Laparoscopic Cholecystectomy · NA · recruiting
- NCT06476054 — Optimal Timing for Laparoscopic Cholecystectomy After Cholecystostomy in Acute Cholecystitis Tokyo II/III Setting · NA · recruiting
- NCT05702775 — Endosonography-guided Gallbladder Drainage vs Non-endoscopic Treatment in Inoperable Acute Cholecystitis · NA · recruiting
Other Texas Tech University Health Sciences Center, El Paso trials
Trials by the same sponsor.
- NCT06016465 — Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs? · EARLY_PHASE1 · recruiting
- NCT05303116 — Do EEG and Neurocognitive Assessments Correlate With COVID Brainfog Symptoms? · completed
- NCT05174988 — Reducing Postoperative Bleeding After Hysterectomy Via Independent Closure of Vaginal Cuff Angles · NA · completed
- NCT05077917 — Cromolyn Sodium for Treatment of COVID-19 Pneumonia · Phase 3 · terminated
- NCT04786379 — Surgical Management of Knee Septic Arthritis · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04167072 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Texas Tech University Health Sciences Center, El Paso
- Last refreshed: 22 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04167072.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing